DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton London Docklands Riverside Hotel

2018年9月19日 (水) 午前 8:00 - 2018年9月20日 (木) 午後 5:00

265 Rotherhithe Street , London, SE16 5HW, United Kingdom

Global Clinical Trials Transparency Conference

Session 2: Sharing and Using Deidentified Individual Participant Data (IPD)

Session Chair(s)

Rebecca  Williams, PHARMD, MPH

Rebecca Williams, PHARMD, MPH

Senior Clinical Trials Subject Matter Expert

Essex, part of Emmes Group, United States

Learn how data repositories such as Vivli and ClinicalStudyDataRequest.com are advancing access to IPD for research purposes and how specific companies are using this resource to support their own disclosure policies. This session will also include a case study describing how academic researchers are using IPD to address questions intended to have clinical impact. Specific features of these data sharing platforms, as well as issues in using IPD will be described.

Speaker(s)

Benjamin  Rotz, RPH

Sponsors/Funders Providing Access to IPD through ClinicalStudyDataRequest.com

Benjamin Rotz, RPH

Eli Lilly and Company, United States

Senior Advisor Global Medical Strategy and Operations

Rebecca  Li, PHD

Vivli – A global data sharing platform

Rebecca Li, PHD

Vivli , United States

Executive Director, Center for Global Clinical Research Data

Sarah  Nevitt

Sarah Nevitt

University of Liverpool, United Kingdom

Department of Biostatistics

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。